From: The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer
Characteristics | n = 63 (%) |
---|---|
Site of rebiopsy | Â |
  Lung | 24 (38.1%) |
  Chest wall | 12 (19.0%) |
  Liver | 9 (14.3%) |
  Lymph nodes | 12 (19.0%) |
  Pancreas | 2 (3.2%) |
  Abdominal wall | 1 (1.6%) |
  Pelvis | 1 (1.6%) |
  Mediastinum | 1 (1.6%) |
  Bone | 1(1.6%) |
Guide for rebiopsy | |
  CT | 39 (61.9%) |
  Ultrasound | 16 (25.4%) |
  Incision | 8 (12.7%) |